These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 27829403)

  • 41. Increased periostin associates with greater airflow limitation in patients receiving inhaled corticosteroids.
    Kanemitsu Y; Matsumoto H; Izuhara K; Tohda Y; Kita H; Horiguchi T; Kuwabara K; Tomii K; Otsuka K; Fujimura M; Ohkura N; Tomita K; Yokoyama A; Ohnishi H; Nakano Y; Oguma T; Hozawa S; Nagasaki T; Ito I; Oguma T; Inoue H; Tajiri T; Iwata T; Izuhara Y; Ono J; Ohta S; Tamari M; Hirota T; Yokoyama T; Niimi A; Mishima M
    J Allergy Clin Immunol; 2013 Aug; 132(2):305-12.e3. PubMed ID: 23791506
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhaled corticosteroids and decline of lung function in community residents with asthma.
    Lange P; Scharling H; Ulrik CS; Vestbo J
    Thorax; 2006 Feb; 61(2):100-4. PubMed ID: 16443705
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Predictors of benefit from high-altitude climate therapy in adults with severe asthma.
    Hashimoto S; Rijssenbeek-Nouwens LH; Fieten KB; Weersink EJ; Bel EH
    Neth J Med; 2018 Jul; 76(5):218-225. PubMed ID: 30019677
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Responsiveness to Parenteral Corticosteroids and Lung Function Trajectory in Adults with Moderate-to-Severe Asthma.
    Denlinger LC; Phillips BR; Sorkness RL; Bleecker ER; Castro M; DeBoer MD; Fitzpatrick AM; Hastie AT; Gaffin JM; Moore WC; Peters MC; Peters SP; Phipatanakul W; Cardet JC; Erzurum SC; Fahy JV; Fajt ML; Gaston B; Levy BD; Meyers DA; Ross K; Teague WG; Wenzel SE; Woodruff PG; Zein J; Jarjour NN; Mauger DT; Israel E
    Am J Respir Crit Care Med; 2021 Apr; 203(7):841-852. PubMed ID: 33290668
    [No Abstract]   [Full Text] [Related]  

  • 45. Comparison of budesonide/formoterol Turbuhaler with fluticasone/salmeterol Diskus for treatment effects on small airway impairment and airway inflammation in patients with asthma.
    Hozawa S; Terada M; Hozawa M
    Pulm Pharmacol Ther; 2011 Oct; 24(5):571-6. PubMed ID: 21624490
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Changes in forced expiratory volume in 1 second over time in patients with controlled asthma at baseline.
    Matsunaga K; Ichikawa T; Oka A; Morishita Y; Kanai K; Hiramatsu M; Akamatsu H; Kawabata H; Kikuchi T; Akamatsu K; Hirano T; Kou Y; Nakanishi M; Minakata Y; Yamamoto N
    Respir Med; 2014 Jul; 108(7):976-82. PubMed ID: 24856920
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhaled corticosteroid dose response in asthma: Should we measure inflammation?
    Anderson WJ; Short PM; Jabbal S; Lipworth BJ
    Ann Allergy Asthma Immunol; 2017 Feb; 118(2):179-185. PubMed ID: 28065396
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Quantitative characterization of circadian rhythm of pulmonary function in asthmatic patients treated with inhaled corticosteroids.
    Zhou D; Li H; Wang Y; Hochhaus G; Sinha V; Zhao L
    J Pharmacokinet Pharmacodyn; 2015 Aug; 42(4):391-9. PubMed ID: 26099861
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Factors influencing the responsiveness to inhaled glucocorticoids of patients with moderate-to-severe asthma.
    Jang AS; Lee JH; Park SW; Lee YM; Uh ST; Kim YH; Park CS
    Chest; 2005 Sep; 128(3):1140-5. PubMed ID: 16162699
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
    Nathan RA; Rooklin A; Schoaf L; Scott C; Ellsworth A; House K; Dorinsky P
    Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The therapeutic effects of inhaled long-acting beta2-adrenergics (LABA) and corticosteroids (ICS) are not affected by their inhalation sequence in moderate/persistent asthma.
    Dal Negro RW; Micheletto C; Tognella S; Trevisan F; Guerriero M
    Eur Ann Allergy Clin Immunol; 2006 May; 38(5):153-7. PubMed ID: 17058847
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of 22 months of treatment with inhaled corticosteroids and/or beta-2-agonists on lung function, airway responsiveness, and symptoms in children with asthma. The Dutch Chronic Non-specific Lung Disease Study Group.
    van Essen-Zandvliet EE; Hughes MD; Waalkens HJ; Duiverman EJ; Pocock SJ; Kerrebijn KF
    Am Rev Respir Dis; 1992 Sep; 146(3):547-54. PubMed ID: 1355640
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Changes in lung function after a bronchial provocation test with cockroach antigens].
    Rosas Vargas MA; del Valle López CA; del Río Navarro BE; Sienra Monge JJ
    Rev Alerg Mex; 2003; 50(1):13-6. PubMed ID: 12822543
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Obesity is a determinant of asthma control independent of inflammation and lung mechanics.
    Farah CS; Kermode JA; Downie SR; Brown NJ; Hardaker KM; Berend N; King GG; Salome CM
    Chest; 2011 Sep; 140(3):659-666. PubMed ID: 21415135
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lung function at 10 yrs is not improved by early corticosteroid treatment in asthmatic children.
    Lødrup Carlsen KC; Devulapalli CS; Mowinckel P; Håland G; Munthe-Kaas MC; Carlsen KH
    Pediatr Allergy Immunol; 2010 Aug; 21(5):814-22. PubMed ID: 19912549
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Is ventilation heterogeneity related to asthma control?
    Svenningsen S; Nair P; Guo F; McCormack DG; Parraga G
    Eur Respir J; 2016 Aug; 48(2):370-9. PubMed ID: 27174885
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lung function changes from childhood to adolescence: a seven-year follow-up study.
    Piccioni P; Tassinari R; Carosso A; Carena C; Bugiani M; Bono R
    BMC Pulm Med; 2015 Apr; 15():31. PubMed ID: 25885675
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serum interferon-gamma is associated with longitudinal decline in lung function among asthmatic patients: the Normative Aging Study.
    Litonjua AA; Sparrow D; Guevarra L; O'Connor GT; Weiss ST; Tollerud DJ
    Ann Allergy Asthma Immunol; 2003 Apr; 90(4):422-8. PubMed ID: 12722965
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Real life clinical study design supporting the effectiveness of extra-fine inhaled beclomethasone/formoterol at the level of small airways of asthmatics.
    Popov TA; Petrova D; Kralimarkova TZ; Ivanov Y; Popova T; Peneva M; Odzhakova T; Ilieva Y; Yakovliev P; Lazarova T; Georgiev O; Hodzhev V; Hodzheva E; Staevska MT; Dimitrov VD
    Pulm Pharmacol Ther; 2013 Dec; 26(6):624-9. PubMed ID: 23769863
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Severe exacerbations predict excess lung function decline in asthma.
    Bai TR; Vonk JM; Postma DS; Boezen HM
    Eur Respir J; 2007 Sep; 30(3):452-6. PubMed ID: 17537763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.